What is the emergency management of acute poisoning in a child?

Emergency Management of Acute Poisoning in Children

Immediately stabilize airway, breathing, and circulation (ABCs) as the absolute first priority, followed by rapid toxin identification and targeted decontamination with activated charcoal when appropriate, while simultaneously contacting poison control for guidance on specific antidotes. 1

Initial Resuscitation and Stabilization

The first minutes are critical and follow standard resuscitation protocols:

• Airway management: Establish a patent airway and provide bag-mask ventilation if needed, progressing to endotracheal intubation for patients unable to protect their airway 1, 2
• Breathing support: Administer 100% oxygen, particularly important in poisonings that impair cellular respiration (e.g., cyanide) 1
• Circulation: Elevate legs for hypotension; initiate IV/IO access for medication administration 3, 2
• Positioning: Place unconscious patients in left lateral head-down position to prevent aspiration 3
• Glucose: Administer glucose injection if the patient is unconscious to address potential hypoglycemia 3

Immediate Life-Threatening Interventions

Address critical complications immediately while resuscitation proceeds:

• Seizures/Status epilepticus: Administer benzodiazepines (diazepam 0.1-0.3 mg/kg IV/IO) 1, 3
• Severe bradycardia: Give atropine 0.02 mg/kg IV/IO (minimum 0.1 mg, maximum 0.5 mg for children) 1
• Respiratory depression from opioids: Naloxone 0.1 mg/kg IV/IO/IM, titrated to restore respiratory drive and protective airway reflexes (not full consciousness) 1
• Extreme agitation: Diazepam if no respiratory depression risk; haloperidol if respiratory depression is present 3

Toxin Identification and Risk Assessment

Rapidly gather information to identify the poison and predict severity:

• Question the patient, family, and witnesses about substance(s) ingested, amount, timing, and circumstances 3, 2
• Examine the immediate environment for pill bottles, containers, or other clues 3
• Recognize toxidromes (constellation of signs/symptoms characteristic of specific poison classes) to guide management when the toxin is unknown 2
• Contact poison control center immediately for assistance with diagnosis, prognosis, and specific management recommendations 3, 4

Gastrointestinal Decontamination

Activated charcoal is the primary decontamination method, but timing and patient selection are critical:

• Activated charcoal: 1 g/kg (typical pediatric dose) administered as soon as possible, ideally within 2 hours of ingestion 3, 4, 5

  • Only give if patient is fully conscious and can swallow safely 3
  • Effective only for toxins adsorbed by charcoal (most medications, but NOT alcohols, metals, hydrocarbons, acids/alkalis) 3
  • May be repeated for sustained-release preparations or toxins with enterohepatic recirculation 5

• Gastric lavage: Reserved ONLY for life-threatening ingestions of substances not adsorbed by charcoal, performed within first few hours 3, 5

  • Carries significant risk of aspiration and esophageal injury 3

• Ipecac syrup: Never use under any circumstances 3, 4

Specific Antidote Administration

Administer toxin-specific antidotes based on identified or suspected poison (see comprehensive dosing table below):

Common Pediatric Poisoning Antidotes:

• Acetaminophen: Acetylcysteine when ingestion occurred within 24 hours; protects liver from necrosis 3

  • Start empirically if emergency care not accessible within 8-10 hours post-ingestion 3

• Opioids: Naloxone 0.1 mg/kg IV/IO/IM; intranasal 2-4 mg, repeated every 2-3 minutes as needed 1

  • Duration shorter than most opioids; continuous monitoring essential 3

• Benzodiazepines with opioids: Administer naloxone FIRST before considering flumazenil 1

  • Flumazenil (0.01 mg/kg) only for pure benzodiazepine poisoning in select low-risk patients 1
  • Flumazenil is contraindicated in seizure disorders, chronic benzodiazepine use, or co-ingestion with proconvulsant drugs (e.g., tricyclic antidepressants) due to risk of refractory seizures and dysrhythmias 1

• Organophosphates/Carbamates:

  • Atropine 0.02 mg/kg IV/IO, doubled every 5 minutes until atropinization achieved (clear chest, HR >80, SBP >80) 1
  • Pralidoxime 20-50 mg/kg for organophosphates 1
  • Benzodiazepines for seizures 1
  • Dermal decontamination with appropriate personal protective equipment 1

• Calcium channel blockers/Beta-blockers:

  • Calcium chloride 20 mg/kg (0.2 mL/kg of 10% solution) IV/IO 1
  • Glucagon 0.05-0.15 mg/kg for beta-blockers 1
  • High-dose insulin (1 U/kg bolus, then 1-10 U/kg/h infusion) with glucose supplementation 1

• Sodium channel blockers (tricyclic antidepressants, cocaine, etc.):

  • Sodium bicarbonate 1-3 mEq/kg IV/IO bolus; maintain pH 7.45-7.55 1

• Digoxin: Digoxin-specific antibody fragments (Fab); 1 vial per 0.5 mg digoxin ingested, or 10-20 vials if critically ill with unknown dose 1

• Cyanide: Hydroxocobalamin 70 mg/kg (preferred); sodium nitrite 6 mg/kg if hydroxocobalamin unavailable 1

Monitoring and Disposition

Hospital admission is mandatory for:

• Any potentially severe poisoning or life-threatening ingestion 3, 2
• Patients at increased risk (very young, comorbidities) 3
• Toxic or unknown dose of potentially lethal substance 3
• Delayed-effect medications (sustained-release formulations, long-acting agents) 6, 4
• Intentional self-poisoning requiring psychiatric evaluation 3

Home monitoring may be appropriate for:

• Witnessed nontoxic exposures with minimal or no symptoms 4
• After poison control consultation confirms low risk 4

Critical Pitfalls to Avoid

• Do not delay resuscitation to obtain detailed history or identify specific toxin 2
• Do not administer activated charcoal to patients with altered mental status or inability to protect airway (aspiration risk) 3, 4
• Do not use flumazenil without excluding seizure risk factors and proconvulsant co-ingestions 1
• Do not assume single-agent poisoning; polysubstance ingestion is common, particularly opioid-benzodiazepine combinations 1
• Do not use succinylcholine or mivacurium for intubation in organophosphate/carbamate poisoning (metabolized by cholinesterase) 1
• Do not forget delayed toxicity: Some medications (sustained-release, long-acting agents) require extended observation despite initial stability 6, 4